Literature DB >> 2896180

Muscles of diabetic (db/db) mice: fibre size, fibre type and the effects of a thermogenic, beta-adrenoceptor agonist.

R E Almond1, M A Cawthorne, M Enser.   

Abstract

The size and morphological characteristics of muscles from diabetic obese (db/db) mice and their normal lean littermates were investigated. The soleus muscles were similar in size in diabetic and normal mice but the biceps brachii and gastrocnemius were significantly lighter in the diabetic animals. In the biceps brachii the small size resulted from an overall reduction in fibre diameter, which was most acute in the fast white fibres, and an increase in the proportion of smaller fast intermediate fibres. Treatment of diabetic mice with BRL 26830 a thermogenic, beta-adrenoceptor agonist, restored the weight, fibre diameter and fibre type composition of the biceps brachii to that of lean littermates. This treatment also increased the weight of the gastrocnemius, together with its protein content. Since BRL 26830 restored normoglycaemia in the diabetic mice, without decreasing their body weight, we suppose that it improved insulin action in their muscles and this, in turn, stimulated muscle growth.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896180

Source DB:  PubMed          Journal:  Int J Obes


  3 in total

1.  Effects on energy utilization of a beta3-adrenergic agonist in rats fed on a cafeteria diet.

Authors:  B Berraondo; A Bonafonte; M P Fernandez-Otero; J A Martinez
Journal:  Eat Weight Disord       Date:  1997-09       Impact factor: 4.652

Review 2.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

3.  Skeletal muscle and fiber type-specific intramyocellular lipid accumulation in obese mice.

Authors:  Nejc Umek; Simon Horvat; Erika Cvetko
Journal:  Bosn J Basic Med Sci       Date:  2021-12-01       Impact factor: 3.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.